In Vivo Evaluation of the Safety and Efficacy of Extracorporeal Circuits for Long-Term Cardiopulmonary Support

Grants and Contracts Details

StatusFinished
Effective start/end date5/31/154/30/17

Funding

  • Xenios AG: $1,587,055.00